Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Genomics Extremers

Eurofins Genomics has launched its Extremer line of "extremely long" oligonucleotides in the US.

The company developed the oligos on its new DNA synthesis platform using high-fidelity chemistry for synthetic biology, next-generation DNA sequencing, and other applications.

Specific uses might include constructing genes with low sequence variability segments; templating in vitro transcription of RNA molecules; introducing large-scale or multi-site mutations; and generating oligos for DNA-directed RNA interference, capture probes, or qPCR control standards.